Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.

ABSTRACT: BACKGROUND:To date, no standard follow-up guidelines exist regarding patients receiving ablation for initial recurrent hepatocellular carcinoma (HCC). We aimed to explore whether intensive follow-up could benefit these patients. METHODS:We reviewed the clinical data of patients who received complete ablation for initial HCC recurrence after curative treatments in our institution from January 2005 to June 2017. Risk factors for second recurrence of HCC were identified by univariate and multivariate analyses. Patients were classified into low- and high-risk groups according to the outcome of the classification and regression model. The patients were further categorized into short- (< 3 months) and long-interval (3-6 months) follow-up subgroups based on their surveillance in the first 2 years

SUBMITTER: Sun X 

PROVIDER: S-EPMC7329485 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature